These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6395799)

  • 1. Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.
    Eng RH; Cherubin C; Smith SM; Buccini F
    Antimicrob Agents Chemother; 1984 Dec; 26(6):850-6. PubMed ID: 6395799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the use of cefotaxime in the treatment of bacterial meningitis.
    Cherubin CE; Eng RH
    Am J Med; 1986 Mar; 80(3):398-404. PubMed ID: 3513559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ; Simberkoff MS; Landesman SH
    J Infect Dis; 1984 Apr; 149(4):562-7. PubMed ID: 6725990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime in the treatment of meningitis.
    Cherubin CE; LeFrock J
    Infection; 1985; 13 Suppl 1():S68-72. PubMed ID: 4055058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation.
    McCracken GH; Threlkeld N; Mize S; Baker CJ; Kaplan SL; Faingezicht I; Feldman WE; Schaad U
    JAMA; 1984 Sep; 252(11):1427-32. PubMed ID: 6381775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
    Eng RH; Cherubin CE; Pechere JC; Beam TR
    J Antimicrob Chemother; 1987 Dec; 20(6):903-11. PubMed ID: 3501999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Escherichia coli meningitis following therapy with moxalactam.
    Broughton RA; Mason EO; Baker CJ
    Pediatr Infect Dis; 1982; 1(1):24-8. PubMed ID: 6217454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Shah PM; Armengaud M; Barza M; Cherubin CE
    Am J Med; 1981 Oct; 71(4):693-703. PubMed ID: 6269429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
    Fitzpatrick BJ; Standiford HC
    Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J; Megraud F; Nelson JR; Martin C
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam antibiotic susceptibility of bacteria responsible for neonatal meningitis.
    Bradsher RW; Ulmer WC
    Chemotherapy; 1983; 29(3):213-7. PubMed ID: 6409519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.